RNA Medicines and Therapies Drive Healthcare Innovation.
Kate Broderick, PhD, discusses the advancements in RNA-based vaccines for targeting flu, cancer, malaria, HIV, and more.
With advancements in targeting capabilities, therapeutic applications, and global disease response,RNA-based medicines are set to reshape the future of healthcare.
The efficacy of some of these RNA- based vaccines is incredibly promising, and they have the potential to completely change the way we approach cancer treatment.
Read the Entire Article
A customized collection of news from foundations from around the Web.
Harvard’s Social Innovation Collaborative is preparing for its 2013 Igniting Innovation Summit on Social Entrepreneurship.